Urgent.News

What's breaking now, across thousands of outlets.

AI

AI-based drug developer Basecamp valued at $800 million after $140 million funding round

The oversubscribed round was led by S32, with participation from Nvidia, Anthropic's Anthology Fund, Catalio Capital Management, the NATO Innovation Fund, the Rockefeller Foundation and Singular, among other investors.

AI-based drug developer Basecamp valued at $800 million after $140 million funding round

We haven't written up this one. Economic Times Tech has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at economictimes.indiatimes.com →

More in AI

More from Wednesday 23 September →